Barclays’s Allergan Inc AGN Stock Holding History

Barclays’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-37,600	Closed	-$7.97M	–	7627
2014 Q4	$7.97M	Sell	37,600 -5,500	-13%	-$1.09M	0.01%	1345
2014 Q3	$7.67M	Sell	43,100 -211,500	-83%	-$35.1M	0.01%	1396
2014 Q2	$43M	Buy	254,600 +200,300	+369%	+$31.2M	0.05%	365
2014 Q1	$6.73M	Sell	54,300 -81,800	-60%	-$9.96M	0.01%	1479
2013 Q4	$15.1M	Sell	136,100 -5,200	-4%	-$497K	0.02%	954
2013 Q3	$12.7M	Sell	141,300 -244,300	-63%	-$21.9M	0.02%	967
2013 Q2	$32.5M	Buy	+385,600	New	+$40M	0.04%	407

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Barclays's AGN Position: Q1 2015 in Review

Barclays sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 193,760 shares — an estimated $41.1M sold.

Barclays first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $74.4M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Barclays reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Barclays sold 193,760 Allergan Inc shares in Q1 2015, an estimated $41.1M.
Barclays first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Barclays's Allergan Inc position peaked at $74.4M in Q2 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.